🍪
🍪🍪🍪🍪
🍪🍪Giant Cell🍪🍪
🍪🍪🍪Rich Tumors🍪🍪🍪
🍪🍪 of Bone 🍪🍪
🍪🍪🍪🍪
🍪
#BSTPath @ariella8 @VijayPatho @Path_Matt @AbhijitSurgPath
☠️Features that do NOT warrant a diagnosis of malignancy in GCT:
✖️Numerous (but typical) mitoses
✖️Necrosis (usually infarct-type)
✖️Intravascular tumor!
✖️“Benign” lung mets (that’s right!)
#BSTPath
@AlanPath @kriyer68 @angelpanizo1
But tumors do not always read 📚🤦🏻♀️
Here is a GCT in the hand🖐🏼.
Patient lost follow up & came back with enlarged tumor.
Bones of ✋🏼and 🦶🏼are uncommon locations for GCT of bone
(not to be confused with tenosynovial GCT which preferentially affects these sites!) #bstpath
Targeted therapy with Denosumab💉 is now used.
Post-treatment changes may be confusing to the pathologist if history is lacking.
Here is an excellent example of post-Denosumab GCT by @kells108 :
Case 🎢:
Gross specimen of an osteolytic lesion in distal tibia in a 10-year-old girl👇🏻
Stay tuned for Part3️⃣❗️
#BSTPath #RolaCoaster
@pembeoltulu